Summary of findings: oral antioxidants (NAC/GSH) vs placebo
Adverse events · adults and children with cystic fibrosis
Summary of findings: oral antioxidants (NAC/GSH) showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes onlyOR 2.92 [0.11, 74.05]1 study · 70 participantsModerate